Literature DB >> 12420236

Pharmacology of recombinant hirudin.

Götz Nowak1.   

Abstract

Hirudin is the anticoagulative product of the salivary glands of the medical leech Hirudo medicinalis. It is characterized by a direct, bifunctional inhibition mechanism and a high, exclusive specificity and a strong ability to bind to thrombin (tight binding). Further characteristics are the organic-chemical structure of hirudin (peptide), which allows only parenteral administration; the missing metabolism in the organism; and the exclusive glomerular filtration of hirudin in kidneys as the effective elimination mechanism. Recombinant hirudin (r-hirudin) is a product of genetic engineering that is identical to the hirudin found in nature and has the same biochemical and pharmacological characteristics as natural hirudin.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12420236     DOI: 10.1055/s-2002-35293

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN: 0094-6176            Impact factor:   4.180


  6 in total

Review 1.  Treatment for disseminated intravascular coagulation in patients with acute and chronic leukemia.

Authors:  Arturo J Martí-Carvajal; Vidhu Anand; Ivan Solà
Journal:  Cochrane Database Syst Rev       Date:  2015-06-24

2.  Network Pharmacology and In Vitro Experimental Verification Reveal the Mechanism of the Hirudin in Suppressing Myocardial Hypertrophy.

Authors:  Mengnan Liu; Gang Luo; Li Dong; Maryam Mazhar; Li Wang; Wenlu He; Yan Liu; Qibiao Wu; Hua Zhou; Sijin Yang
Journal:  Front Pharmacol       Date:  2022-06-15       Impact factor: 5.988

3.  Autoantibodies from Patients with Scleroderma Renal Crisis Promote PAR-1 Receptor Activation and IL-6 Production in Endothelial Cells.

Authors:  Michèle Simon; Christian Lücht; Isa Hosp; Hongfan Zhao; Dashan Wu; Harald Heidecke; Janusz Witowski; Klemens Budde; Gabriela Riemekasten; Rusan Catar
Journal:  Int J Mol Sci       Date:  2021-10-30       Impact factor: 5.923

4.  Synaptic NR2A- but not NR2B-Containing NMDA Receptors Increase with Blockade of Ionotropic Glutamate Receptors.

Authors:  Jakob von Engelhardt; Beril Doganci; Peter H Seeburg; Hannah Monyer
Journal:  Front Mol Neurosci       Date:  2009-10-26       Impact factor: 5.639

Review 5.  Exogenous Integrin αIIbβ3 Inhibitors Revisited: Past, Present and Future Applications.

Authors:  Danique L van den Kerkhof; Paola E J van der Meijden; Tilman M Hackeng; Ingrid Dijkgraaf
Journal:  Int J Mol Sci       Date:  2021-03-25       Impact factor: 5.923

Review 6.  Pharmacological Activities and Mechanisms of Hirudin and Its Derivatives - A Review.

Authors:  Chen Junren; Xie Xiaofang; Zhang Huiqiong; Li Gangmin; Yin Yanpeng; Cao Xiaoyu; Gao Yuqing; Li Yanan; Zhang Yue; Peng Fu; Peng Cheng
Journal:  Front Pharmacol       Date:  2021-04-16       Impact factor: 5.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.